β
Outcome MeasureQuality of Life

EORTC QLQ-C30

European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire

1 Paper in Blossom

Outcome Data Across Studies

Reported results for EORTC QLQ-C30 across 1 study with quantitative data.

Outcome data across 4 study arm–timepoint observations
SD
Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseases
2014Secondary
Full dose LSD(experimental)0837.410.0—
Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseases
2014Secondary
Active placebo LSD(active_comparator)0444.312.7—
Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseases
2014Secondary
Full dose LSD(experimental)42850.014.9—
Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseases
2014Secondary
Active placebo LSD(active_comparator)42436.012.8—

Papers Using EORTC QLQ-C30

Open Accessindividual

Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseases

This double-blind cross-over study (n=12) showed that LSD (200 μg, 2 sessions) in combination with psychotherapy was safe to use and trended towards a positive effect on end-of-life anxiety.

Published
Journal
Journal of Nervous and Mental Disease
Authors
Gasser, P., Holstein, D., Michel, Y., Doblin, R., Yazar-Klosinski, B., Passie, T., Brenneisen, R.

Quick Facts

Full Name
European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire
Domain
Quality of Life
Papers Indexed
1
Score Range
0–100
Interpretation
Higher = better
All Measures